Marijuana Analysis
Why Aurora Overpaid for MedReleaf
Aurora Cannabis Inc. (ACB) announced a deal this morning to buy MedReleaf (LEAF), another licensed producer, for $3.2 billion CAD.…
Bay Street Gone Wild: Why Marijuana Stocks are Overvalued
Capital markets sell-side research has been known for overly optimistic forecasts (think dot-com bubble). One of the biggest reasons for…
MedReleaf Up For Auction: Is the CEO Sending a Message to Investors?
The Globe and Mail reported today that MedReleaf (TSX: LEAF) management is shopping the company around to other larger licensed…
Do US Marijuana Prices Signal Gloomy Days Ahead for Canada?
Recent pricing data from the US is not painting a pretty picture of what could be in store for marijuana…
Pot Stocks now Plagued by the Dreaded ‘Canadian Bank’ Curse
After Bank of Montreal's (BMO) announcement that they are pushing deeper into the marijuana sector yesterday, pot stocks like Canopy…
Pot Stocks Pummelled – Investors Dazed and Confused
The rug has officially been pulled out from underneath one of the largest bubbles in global equities: Canadian pot stocks.…
Marijuana Labeling: No Marketing Department Needed
Canada Releases Restrictive Labeling Guidelines for Retail Marijuana We have always argued at Grizzle that marijuana flower is a commodity. Bullish…
The 4 Horsemen of the Canapocalypse: MedReleaf
CAPACITY BY PROVINCE IN 2022 MEDRELEAF CORP Ticker: LEAF (TSX) Stock Price (Feb 2018): $20.50 Grizzle's Future Target Price: $10.00 Current Annual…
The 4 Horsemen of the Canapocalypse: Aphria
CAPACITY BY PROVINCE IN 2022 APHRIA INC. Ticker: APH (TSX) Stock Price (Mar 2018): $14.24 Grizzle's Future Target Price: $8.00 Current…
The 4 Horsemen of the Canapocalypse: Aurora Cannabis
Aurora Cannabis Inc. stock report (TSE: ACB), assessing its expansion plans, marijuana production capacity, management team, finishing with upside, downside…